// App-Quantinova.ai

479 : Does Liver Stiffness Measurement and Controlled Attenuation Parameter predict portal hypertension, liver related events and overall mortality in individuals with cirrhosis?

Researchers

Presenter

  • Ahmed Hashim

Principal Investigators

  • Bethany Parnell

  • Yazan Haddadin

  • Lucia Macken

  • Stephen Bremner

  • Majella E. Keller

  • Alexandra File

  • Yvonne Gilleece

  • Jeremy A. Tibble

  • Sumita Verma

Medical Centers

  • Brighton and Sussex University Hospitals NHS Trust, Sussex Cancer Centre, Brighton, United Kingdom

  • Brighton & Sussex Medical School, Falmer, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hepatic encephalopathy

  • Liver cancer

  • Portal Hypertension

  • Encephalopathy

  • Hypertension

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved